product summary
Loading...
company name :
Rockland Immunochemicals
product type :
antibody
product name :
Malin Antibody PE/ATTO 594
catalog :
200-363-W58
quantity :
100 µg
clonality :
monoclonal
host :
mouse
conjugate :
ATTO 594
clone name :
S85-18
reactivity :
human
application :
western blot, ELISA
product information
Catalog Number :
200-363-W58
Name :
Anti-Malin (MOUSE) Monoclonal Antibody PE/ATTO 594 Conjugated - 200-363-W58
Display Name :
Malin Antibody PE/ATTO 594
Application Note :
Anti-Malin PE/ATTO 594 Conjugated Antibody is suited for use in Western Blots and Immunocytochemistry. Expect a band approximately ~42 kDa on specific lysates or tissues. Specific conditions for reactivity should be optimized by the end user.
Buffer :
0.02 M Potassium Phosphate, 0.15 M Sodium Chloride, pH 7.2
Clonality :
Monoclonal
Clone ID :
S85-18
Concentration Value :
1mg/mL
Concentration Definition :
by UV absorbance at 280 nm
Conjugation :
AT594
Size :
100 µg
Default Unit :
µg
ELISA Dilution :
1:10,000
Western Blot Dilution :
1:1000
Expiration :
Expiration date is one (1) year from date of opening.
Format :
IgG1
Gene Name :
NHLRC1
Host Animal :
Mouse
General Disclaimer Note :
This product is for research use only and is not intended for therapeutic or diagnostic applications. Please contact a technical service representative for more information. All products of animal origin manufactured by Rockland Immunochemicals are derived from starting materials of North American origin. Collection was performed in United States Department of Agriculture (USDA) inspected facilities and all materials have been inspected and certified to be free of disease and suitable for exportation. All properties listed are typical characteristics and are not specifications. All suggestions and data are offered in good faith but without guarantee as conditions and methods of use of our products are beyond our control. All claims must be made within 30 days following the date of delivery. The prospective user must determine the suitability of our materials before adopting them on a commercial scale. Suggested uses of our products are not recommendations to use our products in violation of any patent or as a license under any patent of Rockland Immunochemicals, Inc. If you require a commercial license to use this material and do not have one, then return this material, unopened to: Rockland Inc., P.O. BOX 5199, Limerick, Pennsylvania, USA.
Immunogen :
Anti-Malin Antibody was created by repeated immunization of mice with a fusion protein of amino acids 2-125 of human Malin.
Packing Type :
Dry Ice
Physical State :
Liquid (sterile filtered)
Preservative :
0.1% (w/v) Sodium Azide
Purity and Specificity :
Anti-Malin Antibody was purified from concentrated tissue culture supernate by Protein G chromatography. BLAST analysis suggests 86% similarity to rat and 77% similarity to mouse.
Species Reactivity :
Human
Stabilizer :
50% (v/v) Glycerol
Storage :
Store vial at -20° C prior to opening. Aliquot contents and freeze at -20° C or below for extended storage. Avoid cycles of freezing and thawing. Centrifuge product if not completely clear after standing at room temperature. This product is stable for several weeks at 4° C as an undiluted liquid. Dilute only prior to immediate use.
Subclass :
IgG1
Synonyms :
E3 ubiquitin-protein ligase NHLRC1, NHLRC 1, NHL repeat containing 1, EPM2A, EPM2B, MGC119262, MGC119264, MGC119265, NHL repeat containing protein 15
Target Species :
Human
Background :
Progressive myoclonic epilepsy type 2 (EPM2), also called Lafora disease, is an autosomal recessive disease characterized by grand mal seizures and/or myoclonus at about 15 years of age. Rapid and severe mental deterioration follows, often with psychotic features. Survival is less than 10 years after onset. Starch-like, endoplasmic reticulum-associated polyglucosans, called Lafora bodies, can be observed in brain, muscle, liver and heart. One cause of Lafora disease is due to mutations in NHLRC1, the gene encoding Malin. Forty-nine different mutations in NHLRC1 have been shown to cause EPM2. Malin, also called NHL repeat-containing protein 1, is a single subunit E3 ubiquitin ligase, containing 6 NHL repeats and 1 RING-type zinc finger. Malin’s RING domain is responsible for its ability to mediate ubiquitination. Malin interacts with and polyubiquitinates Laforin, a protein also implicated in EPM2. Malin localizes to the endoplasmic reticulum and, to a lesser extent, in the nucleus. Malin is expressed in brain, cerebellum, spinal cord, medulla, heart, liver, skeletal muscle and pancreas. Anti-Malin is ideal for researchers interested in Neuroscience, including Neuroleptic malignant syndrome, and pathways related to antigen processing, ubiquination and proteosome degradation.
Immunogen Type :
Recombinant Protein
Low Endotoxin :
No
Sample Size :
No
Target Domain of Reactivity :
N-Terminus
Application Text :
ELISA,Western Blot,
Category :
Primary Antibodies
Conjugation Name :
ATTO 594
UniProt :
Q6VVB1
NCBI :
NP_940988
company information
Rockland Immunochemicals
321 Jones Blvd
Pottstown, PA 19464
tech@rockland.com
https://www.rockland.com/
484-791-3823
headquarters: USA
Rockland Immunochemicals, Inc. produces Phosho-Site Specific Antibodies and Antibody based tools for basic, applied and clinical research. Our laboratory is located west of Philadelphia, Pennsylvania, USA. The technology base of the organization is the experience of its staff scientists in the production and purification of a wide range of antibodies through monoclonal & polyclonal antibody techniques utilizing in vitro and in vivo methods. Rockland's antibodies are suited for individuals performing Western Blotting, ELISA, Immunohistochemistry, Fluorescent Microscopy, High Content Screening and diagnostic kit production. Primary antibodies include Akt Pathway, Apolipoproteins, Apoptosis/Cell Cycle, Cytokines, Cell Signaling, Enzymes, Extracellular Matrix, Transcription Factors (NFkB) and Ubiquitin.